Ventas Inc
VTR80.630USD
+0.550+0.69%
Cierre 11/28, 13:00（ET）Cotizaciones retrasadas 15 min
37.85BCap. mercado
159.03P/E TTM
Más Datos de Ventas Inc Compañía
Ventas, Inc. is a real estate investment trust (REIT). The Company holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. It owns or has investments in approximately 1,387 properties. It operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. It engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), freestanding inpatient rehabilitation facilities (IRFs) and other healthcare facilities.
Información de Ventas Inc
Símbolo de cotizaciónVTR
Nombre de la empresaVentas Inc
Fecha de salida a bolsaApr 02, 1992
Director ejecutivoMr. Peter J. Bulgarelli
Número de empleados498
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 02
Dirección300 N Lasalle Street
CiudadCHICAGO
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal60654
Teléfono13126603800
Sitio Webhttps://www.ventasreit.com/
Símbolo de cotizaciónVTR
Fecha de salida a bolsaApr 02, 1992
Director ejecutivoMr. Peter J. Bulgarelli
Ejecutivos de Ventas Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Debra A. Cafaro
Ms. Debra A. Cafaro
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.66M
--
Mr. Peter J. Bulgarelli
Mr. Peter J. Bulgarelli
Executive Vice President - Outpatient Medical and Research, President and Chief Executive Officer of Lillibridge Healthcare Services, Inc
Executive Vice President - Outpatient Medical and Research, President and Chief Executive Officer of Lillibridge Healthcare Services, Inc
90.48K
-9.95%
Mr. Matthew J. (Matt) Lustig
Mr. Matthew J. (Matt) Lustig
Independent Director
Independent Director
87.81K
+0.91%
Ms. Carey S. Roberts, J.D.
Ms. Carey S. Roberts, J.D.
Executive Vice President, General Counsel, Ethics and Compliance Officer
Executive Vice President, General Counsel, Ethics and Compliance Officer
86.08K
-21.44%
Ms. Melody C. Barnes
Ms. Melody C. Barnes
Independent Director
Independent Director
25.31K
+0.30%
Mr. Walter C. Rakowich
Mr. Walter C. Rakowich
Independent Director
Independent Director
23.81K
+6.36%
Mr. Sean Patrick Nolan
Mr. Sean Patrick Nolan
Independent Director
Independent Director
20.49K
+16.37%
Mr. Maurice S. Smith
Mr. Maurice S. Smith
Independent Director
Independent Director
16.11K
+4.32%
Ms. Marguerite M. Nader
Ms. Marguerite M. Nader
Independent Director
Independent Director
13.47K
+0.56%
Mr. Michael J. (Mike) Embler
Mr. Michael J. (Mike) Embler
Independent Director
Independent Director
8.75K
+0.86%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Debra A. Cafaro
Ms. Debra A. Cafaro
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.66M
--
Mr. Peter J. Bulgarelli
Mr. Peter J. Bulgarelli
Executive Vice President - Outpatient Medical and Research, President and Chief Executive Officer of Lillibridge Healthcare Services, Inc
Executive Vice President - Outpatient Medical and Research, President and Chief Executive Officer of Lillibridge Healthcare Services, Inc
90.48K
-9.95%
Mr. Matthew J. (Matt) Lustig
Mr. Matthew J. (Matt) Lustig
Independent Director
Independent Director
87.81K
+0.91%
Ms. Carey S. Roberts, J.D.
Ms. Carey S. Roberts, J.D.
Executive Vice President, General Counsel, Ethics and Compliance Officer
Executive Vice President, General Counsel, Ethics and Compliance Officer
86.08K
-21.44%
Ms. Melody C. Barnes
Ms. Melody C. Barnes
Independent Director
Independent Director
25.31K
+0.30%
Mr. Walter C. Rakowich
Mr. Walter C. Rakowich
Independent Director
Independent Director
23.81K
+6.36%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2024
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
4.37B
88.68%
Canada
526.58M
10.69%
United Kingdom
30.74M
0.62%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
15.56%
BlackRock Institutional Trust Company, N.A.
7.14%
State Street Investment Management (US)
6.16%
JP Morgan Asset Management
4.99%
Fidelity Management & Research Company LLC
4.32%
Otro
61.84%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
15.56%
BlackRock Institutional Trust Company, N.A.
7.14%
State Street Investment Management (US)
6.16%
JP Morgan Asset Management
4.99%
Fidelity Management & Research Company LLC
4.32%
Otro
61.84%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
60.23%
Investment Advisor/Hedge Fund
25.74%
Pension Fund
5.33%
Hedge Fund
4.06%
Research Firm
1.93%
Bank and Trust
1.79%
Sovereign Wealth Fund
1.22%
Individual Investor
0.52%
Insurance Company
0.09%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
1580
463.30M
98.63%
+2.63M
2025Q2
1585
460.63M
101.36%
+13.50M
2025Q1
1608
457.03M
101.26%
+10.95M
2024Q4
1541
439.23M
100.51%
+17.41M
2024Q3
1486
415.44M
99.13%
+5.84M
2024Q2
1458
401.84M
99.26%
+476.39K
2024Q1
1457
391.72M
96.94%
-10.94M
2023Q4
1442
392.78M
97.61%
-6.38M
2023Q3
1442
395.54M
98.30%
-6.16M
2023Q2
1433
396.22M
98.97%
-682.56K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
71.31M
15.69%
+2.84M
+4.14%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
31.80M
7%
+220.50K
+0.70%
Jun 30, 2025
State Street Investment Management (US)
28.00M
6.16%
+1.39M
+5.22%
Jun 30, 2025
JP Morgan Asset Management
22.74M
5%
-847.37K
-3.59%
Jun 30, 2025
Fidelity Management & Research Company LLC
17.85M
3.93%
+1.02M
+6.07%
Jun 30, 2025
Principal Global Investors (Equity)
15.80M
3.48%
-662.15K
-4.02%
Jun 30, 2025
Geode Capital Management, L.L.C.
12.23M
2.69%
+574.66K
+4.93%
Jun 30, 2025
APG Asset Management US, Inc.
11.76M
2.59%
+121.97K
+1.05%
Jun 30, 2025
Fidelity Institutional Asset Management
6.20M
1.36%
-28.73K
-0.46%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
6.44M
1.42%
+102.06K
+1.61%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
Principal Real Estate Active Opportunities ETF
8.87%
SRH REIT Covered Call ETF
8.01%
Janus Henderson US Real Estate ETF
6.07%
iShares Residential and Multisector Real Estate
5.15%
ALPS Active REIT ETF
4.89%
Fidelity Real Estate Investment ETF
3.99%
Invesco S&P 500 Equal Weight Real Estate ETF
3.57%
iShares Select US REIT ETF
3.44%
Proshares Ultra Real Estate
3.28%
SPDR Dow Jones REIT ETF
3.25%
Ver más
Principal Real Estate Active Opportunities ETF
Proporción8.87%
SRH REIT Covered Call ETF
Proporción8.01%
Janus Henderson US Real Estate ETF
Proporción6.07%
iShares Residential and Multisector Real Estate
Proporción5.15%
ALPS Active REIT ETF
Proporción4.89%
Fidelity Real Estate Investment ETF
Proporción3.99%
Invesco S&P 500 Equal Weight Real Estate ETF
Proporción3.57%
iShares Select US REIT ETF
Proporción3.44%
Proshares Ultra Real Estate
Proporción3.28%
SPDR Dow Jones REIT ETF
Proporción3.25%
Dividendos
Un total de
3.80B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Dec 10, 2024
VTR.NB Final Cash Dividend of gross USD 0.45 paid on Jan 16, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 16, 2025
Dec 31, 2024
Sep 17, 2024
VTR.NB Interim Cash Dividend of gross USD 0.45 paid on Oct 17, 2024 going ex on Oct 01, 2024
Oct 01, 2024
Oct 17, 2024
Oct 01, 2024
May 14, 2024
VTR.NB Interim Cash Dividend of gross USD 0.45 paid on Jul 18, 2024 going ex on Jul 01, 2024
Jul 01, 2024
Jul 18, 2024
Jul 01, 2024
Mar 12, 2024
VTR.NB Interim Cash Dividend of gross USD 0.45 paid on Apr 18, 2024 going ex on Mar 28, 2024
Apr 01, 2024
Apr 18, 2024
Mar 28, 2024
Dec 05, 2023
VTR.NB Final Cash Dividend of gross USD 0.45 paid on Jan 18, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 18, 2024
Dec 29, 2023
Sep 13, 2023
VTR.NB Interim Cash Dividend of gross USD 0.45 paid on Oct 12, 2023 going ex on Sep 29, 2023
Oct 02, 2023
Oct 12, 2023
Sep 29, 2023
May 16, 2023
VTR.NB Interim Cash Dividend of gross USD 0.45 paid on Jul 13, 2023 going ex on Jun 30, 2023
Jul 03, 2023
Jul 13, 2023
Jun 30, 2023
Mar 15, 2023
VTR.NB Interim Cash Dividend of gross USD 0.45 paid on Apr 13, 2023 going ex on Mar 31, 2023
Apr 03, 2023
Apr 13, 2023
Mar 31, 2023
Dec 08, 2022
VTR.NB Final Cash Dividend of gross USD 0.45 paid on Jan 19, 2023 going ex on Dec 30, 2022
Jan 03, 2023
Jan 19, 2023
Dec 30, 2022
Sep 16, 2022
VTR.NB Interim Cash Dividend of gross USD 0.45 paid on Oct 14, 2022 going ex on Sep 30, 2022
Oct 03, 2022
Oct 14, 2022
Sep 30, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Ventas Inc?
Los cinco principales accionistas de Ventas Inc son:
The Vanguard Group, Inc. posee 71.31M acciones, lo que representa el 15.69% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 31.80M acciones, lo que representa el 7.00% del total de acciones.
State Street Investment Management (US) posee 28.00M acciones, lo que representa el 6.16% del total de acciones.
JP Morgan Asset Management posee 22.74M acciones, lo que representa el 5.00% del total de acciones.
Fidelity Management & Research Company LLC posee 17.85M acciones, lo que representa el 3.93% del total de acciones.
The Vanguard Group, Inc. posee 71.31M acciones, lo que representa el 15.69% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 31.80M acciones, lo que representa el 7.00% del total de acciones.
State Street Investment Management (US) posee 28.00M acciones, lo que representa el 6.16% del total de acciones.
JP Morgan Asset Management posee 22.74M acciones, lo que representa el 5.00% del total de acciones.
Fidelity Management & Research Company LLC posee 17.85M acciones, lo que representa el 3.93% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Ventas Inc?
Los tres principales tipos de accionista de Ventas Inc son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
¿Cuántas instituciones poseen acciones de Ventas Inc (VTR)?
A fecha de 2025Q3, 1580 instituciones poseen acciones de Ventas Inc, con un valor de mercado combinado de aproximadamente 463.30M, lo que representa el 98.63% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -2.73%.
¿Cuál es la mayor fuente de ganancias de Ventas Inc?
El FY2024, el segmento empresarial -- generó la ganancia más alta para Ventas Inc, ascendiendo a -- y representando el --% de la ganancia total.
